---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039292"
form_type: "8-K"
ticker: null
cik: "0001642375"
company_name: "Guardion Health Sciences, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:34:34.356045+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Guardion Health Sciences to delist from Nasdaq, dissolve, and liquidate with ~$3.25/share distribution

## Summary
- Voluntary delisting from Nasdaq effective Oct 21; trading suspended Oct 14; Form 25 filed ~Oct 11.
- Certificate of dissolution filed Oct 22; stock transfer books close; no further stock transfers except by will.
- Anticipated liquidating dividend of ~$3.25 per share; no assurance on timing or final amount; reserves possible additional distribution.
- Mark Goldstone appointed Interim President and CEO effective Oct 18; compensation $7,500/month; replaces Janet Hall.
- Company intends to suspend SEC reporting obligations via no-action relief.

## SEC filing metadata
- accession: 0001493152-24-039292
- form_type: 8-K
- cik: 0001642375
- company_name: Guardion Health Sciences, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/0001493152-24-039292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039292
- JSON: https://secwatch.observer/filing/0001493152-24-039292.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039292.txt

## Key facts
- Executive change
  Mark Goldstone was appointed as Interim President and Interim Chief Executive Officer at Guardion Health Sciences, Inc..
  - Action: appointed
  - Role: Interim President and Interim Chief Executive Officer
  source text: On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/0001493152-24-039292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.